Chronic Treatment with Somatostatin Analogues in Recurrent Type 1 Gastric Neuroendocrine Tumors

Background: Type 1 gastric neuroendocrine tumors (GC-1) represent an uncommon subtype of neoplasms. Endoscopic resection has been proposed as the treatment of choice; active surveillance may be performed in those smaller than 1 cm, while gastric surgery may be performed for those with frequent recur...

Full description

Bibliographic Details

Published in:	Biomedicines
Main Authors:	Fernando Sebastian-Valles, Blanca Bernaldo Madrid, Carolina Sager, Elena Carrillo López, Sara Mera Carreiro, Laura Ávila Antón, Noelia Sánchez-Maroto García, Miguel Antonio Sampedro-Nuñez, Jose Ángel Díaz Pérez, Mónica Marazuela
Format:	Article
Language:	English
Published:	MDPI AG 2023-03-01
Subjects:	gastric neuroendocrine tumors gastric carcinoids somatostatin analogs lanreotide octreotide
Online Access:	https://www.mdpi.com/2227-9059/11/3/872